MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jcrc.2022.154152

Медицинская библиотека · Journal of critical care · 2022

End of life decisions in immunocompromised patients with acute respiratory failure.

Burghi Gaston, Metaxa Victoria, Pickkers Peter, Soares Marcio, Rello Jordi, Bauer Philippe R, van de Louw Andry, Taccone Fabio Silvio, Loeches Ignacio Martin, Schellongowski Peter, Rusinova Katerina, Antonelli Massimo, Kouatchet Achille, Barratt-Due Andreas, Valkonen Miia, Pène Frédéric, Mokart Djamel, Jaber Samir, Azoulay Elie, De Jong Audrey, Efraim investigators and the Nine-I study group

СтатьяПеревод в очереди

Аннотация

PURPOSE: To identify patient, disease and organizational factors associated with decisions to forgo life-sustaining therapies (DFLSTs) in critically ill immunocompromised patients admitted to the intensive care unit (ICU) for acute respiratory failure.

MATERIAL AND

METHODS

We performed a secondary analysis of the international EFRAIM prospective study, which enrolled 1611 immunocompromised patients with acute respiratory failure admitted to 68 ICUs in 16 countries between October 2015 and June 2016. Multivariate logistic analysis was performed to identify independent predictors of DFLSTs.

RESULTS

The main causes of immunosuppression were hematological malignancies (50%) and solid tumor (38%). Patients had a median age of 63 yo (54-71). A pulmonologist was involved in the patient management in 38% of cases. DFLSTs had been implemented in 28% of the patients. The following variables were independently associated with DFLSTs: 1) patient-related: older age (OR 1.02 per one year increase, 95% confidence interval(CI) 1.01-1.03,P < 0.001), poor performance status (OR 2.79, 95% CI 1.98-3.93, P < 0.001); 2) disease-related: shock (OR 2.00, 95% CI 1.45-2.75, P < 0.001), liver failure (OR 1.59, 95% CI 1.14-2.21, P = 0.006), invasive mechanical ventilation (OR 1.79, 95% CI 1.31-2.46, P < 0.001); 3) organizational: having a pulmonologist involved in patient management (OR 1.85, 95% CI 1.36-2.52, P < 0.001), and the presence of a critical care outreach services (OR 1.63, 95% CI 1.11-2.38, P = 0.012).

CONCLUSIONS

A DFLST is made in one in four immunocompromised patient admitted to the ICU for acute respiratory failure. Involving a pulmonologist in patient's management is associated with less non beneficial care.

Для цитирования: Burghi Gaston, Metaxa Victoria, Pickkers Peter, Soares Marcio, Rello Jordi, Bauer Philippe R, van de Louw Andry, Taccone Fabio Silvio, Loeches Ignacio Martin, Schellongowski Peter, Rusinova Katerina, Antonelli Massimo, Kouatchet Achille, Barratt-Due Andreas, Valkonen Miia, Pène Frédéric, Mokart Djamel, Jaber Samir, Azoulay Elie, De Jong Audrey, Efraim investigators and the Nine-I study group. End of life decisions in immunocompromised patients with acute respiratory failure.. Journal of critical care. 2022. DOI: 10.1016/j.jcrc.2022.154152.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.